BG Medicine, Inc. (BGMD) - Product Pipeline Analysis

BG Medicine, Inc. (BGMD) - Product Pipeline Analysis

Aug 2012 GlobalData Market Guide37 Pages Price :
$ 750

BG Medicine, Inc. (BGM) is a biotechnology and pharmaceutical company, based in the US. The company discovers, develops and commercializes novel molecular diagnostics tests. It operates through product segments such as Galectin-3 and pipeline. BGM Galectin-3 test for heart failure is a novel diagnostic test for measuring galectin-3 levels in blood plasma or serum. Its pipeline product includes Galectin-3, Galectin-3 Post-MI, AMIPredict, LipidDx, multiple sclerosis and Anti-TNF alpha drug response. The company develops pipeline of molecular diagnostics that are utilized to aid in the diagnosis and treatment of various diseases, including cardiovascular diseases, cancer and central nervous system disorders. BGM is headquartered in Waltham

This report is a source for data, analysis and actionable intelligence on the BG Medicine, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4

Key Facts 5
BG Medicine, Inc. - Major Products and Services 6
BG Medicine, Inc. Pipeline Products by Equipment Type 7
BG Medicine, Inc. Pipeline Products by Development Stage 9
BG Medicine, Inc. Pipeline Products by Therapy Area 11
BG Medicine, Inc. Pipeline Products by Milestone Summary 13
Automated BGM Galectin-3 Assay 15
Automated BGM Galectin-3 Assay Product Status 15
Automated BGM Galectin-3 Assay Product Description 15
Automated BGM Galectin-3 Assay Product Patent Details 15
BGM Galectin-3 - Heart Failure Treatment Decisions 18
BGM Galectin-3 - Heart Failure Treatment Decisions Product Status 18
BGM Galectin-3 - Heart Failure Treatment Decisions Product Description 18
Biomarkers - Enbrel Treatment 19
Biomarkers - Enbrel Treatment Product Status 19
Biomarkers - Enbrel Treatment Product Description 19
Biomarkers - Humira Treatment 20
Biomarkers - Humira Treatment Product Status 20
Biomarkers - Humira Treatment Product Description 20
Biomarkers - Remicade Treatment 21
Biomarkers - Remicade Treatment Product Status 21
Biomarkers - Remicade Treatment Product Description 21
CardioSCORE 22
CardioSCORE Product Status 22
CardioSCORE Product Description 22
CardioSCORE Product Milestone 22
Diagnostic Assay - Multiple Sclerosis 24
Diagnostic Assay - Multiple Sclerosis Product Status 24
Diagnostic Assay - Multiple Sclerosis Product Description 24
Diagnostic Assay - Multiple Sclerosis Product Milestone 24
Galectin-3 Test - Inverness Triage Meter Pro 25
Galectin-3 Test - Inverness Triage Meter Pro Product Status 25
Galectin-3 Test - Inverness Triage Meter Pro Product Description 25
Galectin-3 Test - Inverness Triage Meter Pro Product Milestone 25
Galectin-3 Test - Inverness Triage Meter Pro Product Patent Details 26
LipidDx 28
LipidDx Product Status 28
LipidDx Product Description 28
BG Medicine, Inc. - Key Competitors 29
BG Medicine, Inc. - Key Employees 30
BG Medicine, Inc. - Locations And Subsidiaries 31
Head Office 31
Recent Developments 32
BG Medicine, Inc., Recent Developments 32
May 15, 2012: BG Medicine Reports Q1 2012 Results 32
Mar 13, 2012: BG Medicine Announces Schedule Of Events Related To Galectin-3 And Heart Failure At American College Of Cardiology\'s 61st Annual Scientific Session & Expo 32
Mar 08, 2012: BG Medicine Reports Revenue Of $1.6m In 2011 33
Feb 13, 2012: BG Medicine Appoints Brian S Posner To Board Of Directors 34
Jan 09, 2012: BG Medicine Appoints Eric Bouvier As CEO 34
Nov 30, 2011: BG Medicine Announces Peer-Reviewed Publication On Galectin-3 And Development Of Heart Failure After Acute Coronary Syndrome 34
Jul 27, 2011: BG Medicine Appoints Stephane Bancel As Executive Chairman 35
Jul 18, 2011: BG Medicine Receives ISO 13485 Certification 36
Jun 28, 2011: BG Medicine Appoints Stephen R Miller As Chief Commercial Officer 36

Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Table


BG Medicine, Inc., Key Facts 1
BG Medicine, Inc. Key Pipeline Products by Equipment Type 1
BG Medicine, Inc. Key Pipeline Products by Therapy Area 1
BG Medicine, Inc. Key Pipeline Products by Development Stage 1
BG Medicine, Inc., Key Facts 5
BG Medicine, Inc., Major Products and Services 6
BG Medicine, Inc. Number of Pipeline Products by Equipment Type 7
BG Medicine, Inc. Pipeline Products by Equipment Type 8
BG Medicine, Inc. Number of Pipeline Products by Development Stage 9
BG Medicine, Inc. Pipeline Products by Development Stage 10
BG Medicine, Inc. Number of Pipeline Products by Therapy Area 11
BG Medicine, Inc. Pipeline Products by Therapy Area 12
BG Medicine, Inc. Number of Pipeline Products By Milestone Summary 13
BG Medicine, Inc. Pipeline Products by Milestone Summary 14
Automated BGM Galectin-3 Assay - Product Status 15
Automated BGM Galectin-3 Assay - Product Description 15
Automated BGM Galectin-3 Assay - Patent Details1 15
Automated BGM Galectin-3 Assay - Patent Details2 16
Automated BGM Galectin-3 Assay - Patent Details3 16
Automated BGM Galectin-3 Assay - Patent Details4 17
BGM Galectin-3 - Heart Failure Treatment Decisions - Product Status 18
BGM Galectin-3 - Heart Failure Treatment Decisions - Product Description 18
Biomarkers - Enbrel Treatment - Product Status 19
Biomarkers - Enbrel Treatment - Product Description 19
Biomarkers - Humira Treatment - Product Status 20
Biomarkers - Humira Treatment - Product Description 20
Biomarkers - Remicade Treatment - Product Status 21
Biomarkers - Remicade Treatment - Product Description 21
CardioSCORE - Product Status 22
CardioSCORE - Product Description 22
CardioSCORE - Product Milestone 22
Diagnostic Assay - Multiple Sclerosis - Product Status 24
Diagnostic Assay - Multiple Sclerosis - Product Description 24
Diagnostic Assay - Multiple Sclerosis - Product Milestone 24
Galectin-3 Test - Inverness Triage Meter Pro - Product Status 25
Galectin-3 Test - Inverness Triage Meter Pro - Product Description 25
Galectin-3 Test - Inverness Triage Meter Pro - Product Milestone 25
Galectin-3 Test - Inverness Triage Meter Pro - Patent Details1 26
Galectin-3 Test - Inverness Triage Meter Pro - Patent Details2 26
Galectin-3 Test - Inverness Triage Meter Pro - Patent Details3 27
Galectin-3 Test - Inverness Triage Meter Pro - Patent Details4 27
LipidDx - Product Status 28
LipidDx - Product Description 28
BG Medicine, Inc., Key Employees 30

List of Chart


BG Medicine, Inc. Key Pipeline Products by Equipment Type 1
BG Medicine, Inc. Pipeline Products by Equipment Type 7
BG Medicine, Inc. Pipeline Products by Development Stage 9
BG Medicine, Inc. Pipeline Products by Therapy Area 11
BG Medicine, Inc. Pipeline Products by Milestone Summary 13

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 750
$ 1500

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top